CHME - China Medicine Corporation
NYSE * Healthcare * Medical Distribution
$0.02
+$0.00 (+0.00%)
About China Medicine Corporation
China Medicine Corporation produces and distributes prescription and over the counter drugs, traditional Chinese medicine products, herbs and dietary-supplements, medical devices, and medical formulations in China. The company offers various products for applications, including oncology, high blood pressure, and removal of toxins from food and animal feeds. It provides products that treat stagnation of the heart blood, obstruction of qi in the chest, cardiodynia, headache, and dysmenorrhea; upper respiratory tract infection, acute faucitis, acute tonsillitis, acute gastroenteritis, etc.; acute and chronic hepatitis, deferment hepatitis, cholecystitis, etc.; irregular menstruation, dysmenorrhea, and amenorrhea; anemia and deficiency of vital energy; palpitation, dizziness, and fatigue; and cerebral arteriosclerosis and ischemic stroke. The company distributes its products through a sales network in China. The company was formerly known as Lounsberry Holdings III, Inc. and changed its name to China Medicine Corporation in May 2006. China Medicine Corporation was founded in 2005 and is based in Guangzhou, China.
CHME Key Statistics
Market Cap
$0.47M
P/B Ratio
0.07
Revenue Growth
-0.1%
Profit Margin
0.1%
Employees
281
How CHME Compares to Peers
P/E Rank
N/A
of 5
Margin Rank
#4
of 6
Growth Rank
#6
of 6
Size Rank
#6
of 6
China Medicine Corporation Company Information
- Headquarters
- 2/F, Guangri Tower, Guangzhou, China, 510006, undefined
- Website
- www.cmc621.com/cmc/index.php
- Sector
- Healthcare
- Industry
- Medical Distribution